#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Warm autoimmune haemolytic anaemia Hyperadrenocorticism Oesophageal achalasia Neonatal alloimmune thrombocytopenia Intracranial calcification Palmoplantar pustulosis Myocarditis Bronchopulmonary dysplasia Laryngeal squamous cell carcinoma Wolfram syndrome HER2 gene amplification Congenital cystic kidney disease Pancreatic carcinoma Testicular leiomyosarcoma Uveitis More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome – Basic Information Factor VIII deficiency Cerebral arteriovenous malformation haemorrhagic – Life with Disease Chondrosarcoma metastatic – Basic Information Medulloblastoma – Trials in Disease Crigler-Najjar syndrome – Trials in Disease Haemophilia B with anti factor IX – Diagnostics Alport’s syndrome – Trials in Disease Mast cell activation syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zidovudine Rasburicase Op-1250 Soya Oil, Purified [18F]Fluoro-Peg-Folate Potassium Chloride Nvdx3 Immunoglobulins, Normal Human Staphylococcus Aureus Ozanimod Hydrochloride Rgx-202 Calcium Chloride Hexahydrate Pembrolizumab Olive Oil, Refined Ilofotase Alfa LY3537031 Gsk6097608 Azelastine Ro7589655 Desoximetasone More therapies…

    Learn about Your Condition

    Myocarditis post infection Retinal neovascularisation Fungal infection Respiratory failure Duchenne muscular dystrophy Mucopolysaccharidosis I End stage renal disease Myotonia Blood iron increased Immunosuppression Thrombotic microangiopathy Arginase deficiency Dry mouth Invasive breast carcinoma Dent's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia

    Recruiting

    3 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium Czechia France Germany Hungary +3

  • Study on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    Denmark Finland France Ireland Italy Norway +2

  • Study on the Effects of Amylase, Protease, and Rizolipase for Patients After Gastrectomy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Amylase
    • Protease
    • Rizolipase
    Germany

  • Study on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ivosidenib
    Austria Belgium France Germany Ireland Italy +4

  • Study of Pre-Operative Treatments with Sotorasib and Drug Combination for Patients with Resectable Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • 4-[1-[[6-[[4-(Trifluoromethyl)Phenyl]Methyl]-6-Azaspiro[2.5]Octane-7-Carbonyl]Amino]Cyclopropyl]Benzoic Acid
    • Balstilimab
    • Botensilimab
    Italy
Previous Page
1 … 583 584 585 586 587 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!